SEC Form 4/A · accession 0001349929-16-000094
CANCER GENETICS, INC · CGIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
This is an amendment (Form 4/A). It replaces an earlier filing for the same period.
Reporting owner
John Pappajohn
Director · 10% Owner
Period of report
May 25, 2016
Accepted (ET)
Jul 19, 2016 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001349929
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per shareF1,F2 | May 25, 2016 | P$0 | 317,820 | — | A | 2,094,609 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The reported securities were purchased in a registered direct offering and a concurrent private placement, both of which closed on May 25, 2016.
- F2The reported securities consist of one share of common stock, par value $0.0001 per share (the "Common Stock") and a warrant to purchase one-half of a share of Common Stock. The purchase price for the reported securities was $2.2025 per share and warrant.
Remarks
The total number of shares reported has been decreased by 5,000 shares due to a typographical error in the original filing. The warrants have been omitted from this amendment because they were accurately reported in the original filing.